Preserved central nervous system functioning after use of romidepsin as a latency-reversing agent in an HIV cure strategy

by on 7 de març de 2022 with No hi ha comentaris
  • Muñoz-Moreno, J. A., Carrillo-Molina, S., Martinez-Zalacain, I., Miranda, C., Manzardo, C., Coll, P., . . . Grp, B. C.-N. S. (2022). Preserved central nervous system functioning after use of romidepsin as a latency-reversing agent in an HIV cure strategy. Aids, 36(3), 363-372. https://doi.org/10.1097/qad.0000000000003121

Deixa un comentari

L'adreça electrònica no es publicarà. Els camps necessaris estan marcats amb *